BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1345223)

  • 1. Impaired vasodilator and chronotropic responses to 5-hydroxytryptamine in two models of hypertension-associated cardiac hypertrophy.
    Mertens MJ; Pfaffendorf M; van Zwieten PA
    Blood Press; 1992 Dec; 1(4):254-9. PubMed ID: 1345223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of cardiac tissues with moderate and advanced hypertrophy to calcium ions.
    Mertens MJ; Pfaffendorf M; Van Zwieten PA
    Gen Pharmacol; 1995 Mar; 26(2):399-406. PubMed ID: 7590094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed inotropic response to beta-adrenoceptor agonists in the presence of advanced cardiac hypertrophy in hearts from rats with induced aortic stenosis and from spontaneously hypertensive rats.
    Mertens MJ; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 1992 Nov; 10(11):1361-8. PubMed ID: 1362434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANP and bradycardic reflexes in hypertensive rats: influence of cardiac hypertrophy.
    Thomas CJ; Head GA; Woods RL
    Hypertension; 1998 Sep; 32(3):548-55. PubMed ID: 9740624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N; Head GA
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.
    Anderson PG; Bishop SP; Digerness SB
    Circ Res; 1989 Jun; 64(6):1127-36. PubMed ID: 2524290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced muscarinic cholinoceptor density and sensitivity in various models of experimental cardiac hypertrophy.
    Mertens MJ; Batink HD; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Auton Pharmacol; 1995 Dec; 15(6):465-74. PubMed ID: 8920163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotropic response to cardiac sympathetic nerve stimulation in spontaneously hypertensive rats.
    Masuda Y; Matsuoka H
    Can J Physiol Pharmacol; 1997 Feb; 75(2):97-103. PubMed ID: 9114930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve.
    Wangler RD; Peters KG; Marcus ML; Tomanek RJ
    Circ Res; 1982 Jul; 51(1):10-8. PubMed ID: 6211294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term cardiac hypertrophy on coronary vasodilator reserve in SHR rats.
    Peters KG; Wangler RD; Tomanek RJ; Marcus ML
    Am J Cardiol; 1984 Dec; 54(10):1342-8. PubMed ID: 6239536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
    Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
    Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endothelium-dependent vasodilation and vasoconstriction in coronary arteries from spontaneously hypertensive rats.
    Fuchs LC; Nuno D; Lamping KG; Johnson AK
    Am J Hypertens; 1996 May; 9(5):475-83. PubMed ID: 8735179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats.
    Leenen FH; Yuan B
    Hypertension; 2001 Feb; 37(2):209-15. PubMed ID: 11230273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medium-chain triglyceride (MCT) application to SHR on cardiac function, hypertrophy and expression of endothelin-1 mRNA and other genes.
    Shimojo N; Miyauchi T; Iemitsu M; Irukayama-Tomobe Y; Maeda S; Ohkubo T; Tanaka Y; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S181-5. PubMed ID: 15838274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired inotropic response to alpha 1- but not to beta-adrenoceptor stimulation in isolated hearts from spontaneously hypertensive rats.
    Mertens MJ; Batink HD; Pfaffendorf M; van Zwieten PA
    J Hypertens; 1992 Feb; 10(2):143-8. PubMed ID: 1348261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced nociceptive effects of intravenous serotonin (5-HT) in the spontaneously hypertensive rat.
    Lewis SJ; Meller ST; Brody MJ; Gebhart GF
    Clin Exp Hypertens A; 1991; 13(5):849-57. PubMed ID: 1773517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibits isoprenaline-induced positive inotropic effects in normal, but not in hypertrophied rat heart.
    Kotchi Kotchi E; Weisselberg T; Röhnert P; Preiss M; Heinroth-Hoffmann I; Osten B; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1998 May; 357(5):579-83. PubMed ID: 9650813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
    Demirci B; McKeown PP; Bayraktutan U
    J Hypertens; 2005 Dec; 23(12):2219-27. PubMed ID: 16269964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.